AXGN Axogen Q4 2025 EPS falls nearly 30 percent short of estimates shares post modest gain today Moderna Inc MRNA Competitive Landscape Shifts Following HeadtoHead COVID Vaccine Trial Results and Peer Catalyst Updates SDRL Seadrill posts massive Q4 2025 EPS beat sending shares slightly higher as investors cheer results